Patra C., Hussein Z., Ace V.D., Misnik E.V., Rybalko D.S., Salimova A.A., Ereshko D.S., Dubovichenko M.V., Nour M., Drozd V.S., Kolpashchikov D.M. The efficacy of oligonucleotide-based gene therapeutics in gene silencing. Theranostics. 2026. Vol. 16. No. 2. pp. 599-616.. doi: 10.7150/thno.121775
Patra C.K., Smirnov V.V., Drozd V.S., Hussein Z., Rybalko D.S., Kozlova A.V., Nour M., Zemerova T.P., Kolosova O.S., Kalnin A.Y., El-Deeb A. Towards the Development of a DNA Automaton: Modular RNA-cleaving Deoxyribozyme Logic Gates Regulated by miRNAs. Analyst. 2024. Vol. 149. No. 6. pp. 1947-1957.. doi: 10.1039/D3AN02178E
OPTIMIZATION OF AFFINITY AND STABILITY OF SELECTED APTAMER FOR BSA
Dubovichenko M.V., Nedorezova D.D., Patra C., Drozd V.S., Andrianov V.S., Ashmarova A.I., Nnanyereugo V., El-Deeb A.A., Kolpashchikov D.M. Marker-dependent cleavage of RNA by binary (split) DNAzyme (BiDz) and binary DNA machines (BiDNM). ChemBioChem. 2024. Vol. 25. No. 24. pp. e202400665.. doi: 10.1002/cbic.202400665
MULTICOMPONENT ASO AGENT FOR INTRACELLULAR OVEREXPRESSION AND MUTATION RECOGNITION
DNA construct based on DNAzymes for selective SNP detection in KRAS
Selective DNA-machine for SNP Detection in KRAS
Patra C., Eldeeb A.A. Thresholding DNA nanomachine as a highly cooperative and efficient enzyme-like system for controlled RNA cleavage. ChemMedChem. 2023. Vol. 18. No. 7. pp. e202300040.. doi: 10.1002/cmdc.202300040
Genotyping of Cancer-associated KRAS Mutation by Deoxyribozyme Based 4-arms DNA Machine
Towards DNA-robot for Auto Diagnosis and Cancer Treatment
Использование триазиниламидофосфата для внутриклеточной доставки АСО и сложных ДНК-конструкций//OpenBio
Development of a DNA-based Nanoconstruction to Detect Low Concentrations of Cancer-associated Molecules
Development of DNA-based Machines for Selective Detection of Cancer-associated RNA
Development Deoxyribozyme Based Machine for Genotyping of Cancer-associated KRAS Mutation
Towards Intracellular Overexpression and Mutation Recognition
КОНСТРУКЦИИ НА ОСНОВЕ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ ШИРОКОГО СПЕКТРА ПРИМЕНЕНИЙ
AN shRNA RELEASING DNA NANOSTRUCTURE WITH ONCOMARKER-DEPENDENT ACTIVATION
INVESTIGATION OF INTRACELLULAR DELIVERY OF THERAPEUTIC NUCLEIC ACIDS WITH THE HELP OF LIPID CONJUGATES AND DNA NANOSTRUCTURES
Oncomarker modulated RNA cleavage Using threshold Binary DNAzyme
DESIGN OF A DNA MACHINE BASED ON SHRNA FOR MARKER-DEPENDENT RNA INTERFERENCE
DETECTION OF NUCLEIC ACID BASED CANCER MARKERS INSIDE THE CELL
COOPERATIVITY FOR CANCER TREATMENT: A THRESHOLDING DNA LOGIC GATE THAT IS ACTIVE AT HIGH CONCENTRATIONS OF CANCER MARKER RNA